Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Immunological Reviews|November 6, 2007
The adaptive immune response to sporadic cancerGerald Willimsky, Thomas BlankensteinNature|September 2, 2005
Sporadic immunogenic tumours avoid destruction by inducing T-cell toleranceGerald Willimsky, Thomas BlankensteinFrontiers in Immunology|February 11, 2025
T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapyMeng-Tung Hsu, Gerald Willimsky, Leo Hansmann, et al.International Journal of Cancer|February 9, 2005
Tumor-induced antibodies resemble the response to tissue damageSusanne Preiss, Thomas Kammertoens, Christoph Lampert, et al.The Journal of Clinical Investigation|March 5, 2013
Virus-induced hepatocellular carcinomas cause antigen-specific local toleranceGerald Willimsky, Karin Schmidt, Christoph Loddenkemper, et al.Journal for Immunotherapy of Cancer|October 27, 2022
H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline gliomaLena Immisch, George Papafotiou, Oliver Popp, et al.Blood|January 12, 2013
Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transferKarin Schmidt, Serena Zilio, Jan C Schmollinger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2018
Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell PolyomavirusIoannis Gavvovidis, Matthias Leisegang, Gerald Willimsky, et al.BMC Medical Genomics|November 29, 2019
Identification and ranking of recurrent neo-epitopes in cancerEric Blanc, Manuel Holtgrewe, Arunraj Dhamodaran, et al.Frontiers in Immunology|March 6, 2023
Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptorsLena Immisch, George Papafotiou, Nerea Gallarín Delgado, et al.Pageof 5